National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: 24-Month Outcomes of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder

Pediatrics

Volumn 113, Issue 4 I, 2004, Pages 754-761

  Jensen, Peter S ^a   Arnold, L Eugene ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

Attention deficit; Behavior therapy; Hyperactivity; Stimulant medication

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR MODIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SCHOOL CHILD; SYMPTOM; TREATMENT PLANNING;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CHILD; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 1842533979     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.4.754     Document Type: Article

References (31)

1. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073-1086
2. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1088-1096
3. Conners CK, Epstein J, March JS, et al. Multimodal treatment of ADHD (MTA): an overall measure of treatment outcome. J Am Acad Child Adolesc Psychiatry. 2001;40:159-167
4. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001; 40:168-179
5. Hinshaw SP, Owens EB, Wells KC, et al. Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol. 2000;28: 555-568
6. Wells KC, Epstein JN, Hinshaw SP, et al. Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol. 2000; 28:543-553
7. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40:147-158
8. March JS, Swanson JM, Arnold LE, et al. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD. J Abnorm Child Psychol. 2000;28:527-541
9. Paternite CE, Loney J, Salisbury H, Whaley MA. Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. J Child Adolesc Psychopharmacol. 1999;9: 169-184
10. Gillberg C, Melander H, von Knorring AL, et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1997;54:857-864
11. Hechtman L, Abikoff H. Multimodal treatment plus stimulants vs. stimulant treatment in ADHD children: results from a two year comparative treatment study. In: Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Washington, DC: American Academy of Child and Adolescent Psychiatry; 1995:63
12. Pelham WE Jr, Fabiano GA. Behavior modification. Child Adolesc Psychiatr Clin North Am. 2000;9:671-688
13. Arnold LE, Abikoff HB, Cantwell DP, et al. NIMH collaborative multimodal treatment study of children with ADHD (MTA): design challenges and choices. Arch Gen Psychiatry. 1997;54:865-870
14. Hinshaw S, March J, Abikoff H, et al. Comprehensive assessment of childhood ADHD in the context of a multisite, multimodal clinical trial. J Attention Disord. 1997;1:217-234
15. Achenbach TM, McConaughy SH, Howell CT. Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull. 1987;101:213-232
16. Shaffer D, Fisher P, Dulcan M, et al. The second version of the NIMH Diagnostic Interview Schedule for Children (DISC-2). J Am Acad Child Adolesc Psychiatry. 1996;35:865-877
17. Swanson JM. School-Based Assessments and Interventions for ADD Students. Irvine, CA: KC Publications; 1992
18. Wechsler D. Wechsler Individual Achievement Test-Manual. San Antonio, TX: The Psychological Corporation; 1992
19. Gresham FM, Elliott SN. Social Skills Rating System-Parent, Teacher, and Child Forms. Circle Pines, MN: American Guidance Systems; 1989
20. Laird NM, Ware JH. Random effect models for longitudinal data. Biometrics. 1982;38:963-974
21. Bryk AS, Raudenbush SW. Toward a more appropriate conceptualization of research on school effects: a three-level hierarchical linear model. Am J Educ. 1988;97:68-108
22. Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH Treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry. 1993;50:739-750
23. Hedeker D, Gibbons RD, Flay BR. Random-effects regression models for clustered data with an example from smoking prevention research. J Consult Clin Psychol. 1994;62:757-765
24. Kuo M, Mohler B, Raudenbush SL, Earls FJ. Assessing exposure to violence using multiple informants: application of hierarchical linear model. J Child Psychol Psychiatry. 2000;41:1049-1056
25. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:12-19
26. Jacobson NS, Roberts LJ, Bems SB, McGlinchey JB. Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. J Consult Clin Psychol. 1999;67: 300-307
27. Marcus SM, Gibbons RD. Estimating the efficacy of receiving treatment in randomized clinical trials with noncompliance. Health Serv Outcomes Res Method. 2001;2:247-258
28. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2003;113:762-769
29. Krupnick JL, Sotsky SM, Simmens S, Moyer J. The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1996;64:532-539
30. Carlson CL, Pelham WE, Milich R, Dixon J. Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with ADHD. J Abnorm Child Psychol. 1992;20:213-231
31. Arnold LE, Chuang S, Davies M, et al. Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. J Abnorm Child Psychol. 2003;32:39-51